Water Quality in BETHEL, CT (06801)
EPA violation data for public water systems serving ZIP code 06801.
384
Total Violations
29
Health-Based
355
Monitoring / Reporting
379
Resolved
What does this mean?
379 of 384 violations have been resolved. 29 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 355 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (384 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 22, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 22, 2025 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Aug 9, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Aug 9, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 28, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 28, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 28, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 28, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 20, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 20, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 20, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 20, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 30, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 29, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 29, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 29, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 29, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 29, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 29, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 5, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 5, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Oct 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Oct 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Oct 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Oct 16, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 1, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 1, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Aug 9, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Aug 9, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 5, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 5, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Jun 16, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Jun 16, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Jun 16, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Jun 16, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 25, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 20, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 20, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 20, 2023 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 12, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 12, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 12, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 12, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Aug 9, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Aug 9, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Apr 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Nitrite | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Nitrite | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 25, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 28, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Jan 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 5, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 5, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 5, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 5, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 5, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 5, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 5, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 5, 2022 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Barium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increase in blood pressure |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Allergic dermatitis |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nickel | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Kidney damage |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Nerve damage or thyroid problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Barium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increase in blood pressure |
| Barium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increase in blood pressure |
| Chromium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Allergic dermatitis |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 4, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 4, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 4, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 4, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Aug 9, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Aug 9, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(6)
Consumer Confidence Rule
71
Revised Total Coliform Rule
3B
Lead and Copper Rule
66
Lead and Copper Rule
66
Public Notice
75
Public Notice
75
2024(36)
CARBON, TOTAL
27
CARBON, TOTAL
27
CARBON, TOTAL
27
CARBON, TOTAL
27
CARBON, TOTAL
27
CARBON, TOTAL
27
CARBON, TOTAL
27
CARBON, TOTAL
27
Nitrate
03
Revised Total Coliform Rule
3A
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
Lead and Copper Rule
66
Lead and Copper Rule
66
Consumer Confidence Rule
72
Consumer Confidence Rule
72
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Lead and Copper Rule
66
Lead and Copper Rule
66
2023(53)
Nitrate
03
Nitrite
03
Nitrite
03
Nitrite
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrite
03
Nitrite
03
Nitrite
03
Lead and Copper Rule
66
Lead and Copper Rule
66
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
2B
Revised Total Coliform Rule
2B
Revised Total Coliform Rule
2B
Revised Total Coliform Rule
2B
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Consumer Confidence Rule
72
Consumer Confidence Rule
72
Public Notice
75
Public Notice
75
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Groundwater Rule
45
Groundwater Rule
45
Groundwater Rule
45
Groundwater Rule
45
Lead and Copper Rule
66
Lead and Copper Rule
66
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
E. COLI
34
E. COLI
34
E. COLI
34
2022(234)
Nitrite
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrite
03
Nitrite
03
Nitrate
03
Nitrite
03
Lead and Copper Rule
66
Lead and Copper Rule
66
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
72
Consumer Confidence Rule
72
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Nitrite
03
Nitrite
03
Nitrite
03
Nitrite
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Lead and Copper Rule
51
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
Revised Total Coliform Rule
3A
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
E. COLI
19
Nitrite
03
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
Nitrite
03
Nitrite
03
Nitrite
03
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
Revised Total Coliform Rule
3A
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
TTHM
27
TTHM
27
TTHM
27
TTHM
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Public Notice
75
Public Notice
75
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
E. COLI
19
Revised Total Coliform Rule
3A
E. COLI
19
E. COLI
19
E. COLI
19
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
E. COLI
19
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2021(55)
Selenium
03
Barium
03
Chromium
03
Chromium
03
Arsenic
03
Arsenic
03
Arsenic
03
Selenium
03
TTHM
27
TTHM
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Thallium, Total
03
Thallium, Total
03
Thallium, Total
03
Nickel
03
Nickel
03
Nickel
03
Mercury
03
Mercury
03
Cadmium
03
Cadmium
03
Cadmium
03
Mercury
03
CYANIDE
03
CYANIDE
03
CYANIDE
03
Selenium
03
Antimony, Total
03
Antimony, Total
03
Antimony, Total
03
Beryllium, Total
03
Beryllium, Total
03
Beryllium, Total
03
Barium
03
Barium
03
Chromium
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Lead and Copper Rule
66
Lead and Copper Rule
66
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Revised Total Coliform Rule
2A
Consumer Confidence Rule
72
Consumer Confidence Rule
72
Consumer Confidence Rule
71
Consumer Confidence Rule
71
How Does This Compare?
BETHEL (06801) has 384 recorded violations, including 29 health-based. 5 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
Activated Carbon Filter
Excellent for removing chlorine, chloramine, and disinfection byproducts like THMs and HAAs. Available as pitcher filters, countertop, or under-sink units.
Targets:THMs, HAAs, Chlorine, Chloramine, Taste & Odor
Look for:NSF/ANSI 42 & 53 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.